Business Context and Reporting Period
This Form 8-K was filed by Aziyo Biologics, Inc. (not Elutia Inc.) on November 21, 2022. The company is an emerging growth company incorporated in Delaware, with its principal executive offices in Silver Spring, MD. Its Class A Common Stock trades on The Nasdaq Capital Market under the symbol AZYO.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, or margins. It focuses exclusively on debt and liquidity covenants related to a senior secured term loan facility.
- Total Debt Facility: $25 million aggregate principal amount (including $4 million contingent on future metrics).
- Liquidity Covenant: Required to maintain minimum liquidity of $5.0 million until the Step-Up Date.
- Post-Step-Up Liquidity: Required to maintain the greater of $5.0 million or the Operating Burn for the two prior consecutive fiscal quarters.
Material Changes
The company entered into an Amendment Letter to its Credit Agreement (originally dated August 10, 2022) to modify a key covenant deadline:
- Step-Up Date Extension: The minimum liquidity step-up date was extended from November 21, 2022 to December 16, 2022.
- Context: This amendment provides additional time before the company must meet the higher liquidity threshold based on its operating burn rate.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operations, or discussion of general risks. The primary contingency noted is the requirement to achieve specified operational and financial metrics by September 30, 2023, to make the remaining $4 million of the credit facility available.
Investor Verification Checklist
- Verify the company name is Aziyo Biologics, Inc. (Ticker: AZYO), as the request metadata incorrectly listed "Elutia Inc."
- Confirm the company's current cash position to ensure compliance with the $5.0 million minimum liquidity requirement through the new December 16, 2022 deadline.
- Review the definition of "Operating Burn" in the Credit Agreement to understand the future liquidity threshold post-December 16, 2022.
- Monitor progress toward the operational and financial metrics required by September 30, 2023, to unlock the additional $4 million in funding.